Navigation Links
Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss
Date:7/5/2011

es imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this statement related to our product candidates is preliminary and in
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)...  Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that ... ROTH Conference on Wednesday, March 11, 2015, at 10:30 a.m. ... Carlton Laguna Niguel in Dana Point, CA. ... and Chief Executive Officer of Palatin Technologies, will provide an ... About Palatin Technologies, Inc. Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Prime Therapeutics ... more than 26 million members, today released the following ... (FDA) approval of the first biosimilar to enter the ... Drug Administration (FDA) approval of Sandoz,s Zarxio® to treat ... patients, is a major milestone in our country,s journey ...
(Date:3/6/2015)... März 2015  Unfors RaySafe, Marktführer für ... dem European Congress of Radiology (ECR) in ... 1.000. Installation seines Systems zur Strahlendosimetrie RaySafe ... http://photos.prnewswire.com/prnh/20150304/179432LOGO Das RaySafe i2 ... Informationen über die Dosis der Röntgenstreustrahlung gibt, ...
Breaking Medicine Technology:Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 3
... Presented at the 2008 AACR Annual Meeting, SOMERSET, ... today announced that Dr. Intae Lee with the University ... a,promising radiation sensitizer for lung cancer treatment. Dr. Lee ... a poster at the 2008 American,Association of Cancer Research ...
... April 14, at 8:30 a.m. E.T. at ... http://www.isispharm.com , ... ) announced additional results from its,ongoing Phase 2 open-label extension (OLE) ... exposed to,mipomersen for as long as 16 months, the safety profile ...
Cached Medicine Technology:Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 2Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6
(Date:3/6/2015)... 06, 2015 First Choice Emergency Room ... new facility is located at 13351 W. Bowles Avenue, Littleton, ... team is ready 24-7 to provide the highest quality emergency ... Medical Director of First Choice Emergency Room Littleton. ... the South Metro Denver Chamber of Commerce and a medical ...
(Date:3/6/2015)... GA (PRWEB) March 06, 2015 ... announced the release of a Clostridium Difficile (C ... providers. The C Diff use case is the ... that span hospital acquired infections, chronic conditions, and ... platform, the C Diff solution flags at risk ...
(Date:3/6/2015)... Nolen, the largest family-owned pest control company in America, ... first independently-owned and operated franchise in North Carolina, serving ... Rock Hill, SC area. The ribbon cutting ceremony was ... , The Truly Nolen Carolina team has ... control industry. Locally owned and operated by local Charlotteans, ...
(Date:3/6/2015)... In a new study conducted at a Warsaw hospital, ... pain was their first mesothelioma symptom. Surviving Mesothelioma has just ... to read it now. , Doctors at the Central ... mesothelioma patients between 2006 and 2012 and found ... that first prompted them to see a doctor. For some, ...
(Date:3/6/2015)... March 06, 2015 The Gluten-Free ... Celiac Association, is pleased to announce that Dufflet ... Rosenberg, has expanded their product line of gluten-free ... as scrumptious and as satisfying as any of ... scratch, and never contains hydrogenated fats or oils, ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4
... now for almost 40 years for treatment skin // ... useful in treating cancer as it has been shown to ... reported by international team of scientists. Leslie Wilson, professor of ... The results are published in online edition of the Proceedings ...
... and Drug Administration (FDA) has recently approved of a ... disease that affects almost everybody. Gingivitis is an inflammation ... gums. It is believed that plaque-forming bacteria that live ... a cause of gingivitis and substances released by the ...
... study of the smokers reveals that the smokers may differ ... sensitivity to smoking. ,Researchers have found that the urge ... smokers according to the brain responses to the smoking habit. ... the brain images of smokers in a bid to study ...
... A good night’s sleep can trigger brain actions to improve ... Beth Israel Deaconess Medical Center. ,Using the functional magnetic ... active and the inactive parts of the brain during sleep ... ,When a person gets the information inputs a new memory ...
... the most common and deadly cancer worldwide. About 1.4 million ... which // 85% will die before 2010. Habit of smoking ... increasing in low and middle income countries. The most important ... disease causes 5 million deaths a year. ,In many ...
... at Saint Louis University have suggested that patients going for ... caffeine intake interferes with PET/CT image results when there is ... university presented his study that looks at the relationship ... the tracer used in the PET scan called FDG at ...
Cached Medicine News:Health News:Aggressive Tobacco taxation policy can reduce cigarette smoking, 2
20 GA TITANIUM RETINAL FORCEPS...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Permits rotation of the globe during examination. Overall length,123mm....
Medicine Products: